Seminar: Regulation of LRRK2: Identifying Vulnerabilities for Parkinson’s Disease Therapeutics

Andres Leschziner, PhD, Professor, Department of Cellular & Molecular Medicine, and Department of Molecular Biology, University of California - San Diego